| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/25/2001 | DE10016846A1 New cell constructs from activated T-cells of patients useful as a medicament |
| 10/25/2001 | CA2747325A1 Albumin fusion proteins |
| 10/25/2001 | CA2406955A1 Sheep lice, bovicola ovis, allergen treatment |
| 10/25/2001 | CA2406390A1 Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase |
| 10/25/2001 | CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 10/25/2001 | CA2406196A1 Therapeutic uses for mesenchymal stromal cells |
| 10/25/2001 | CA2406180A1 Viruses comprising mutant ion channel protein |
| 10/25/2001 | CA2406171A1 Reversible immortalization of cells |
| 10/25/2001 | CA2405709A1 Albumin fusion proteins |
| 10/25/2001 | CA2405701A1 Albumin fusion proteins |
| 10/25/2001 | CA2405563A1 Albumin fusion proteins |
| 10/25/2001 | CA2405557A1 Albumin fusion proteins |
| 10/25/2001 | CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 10/25/2001 | CA2405550A1 Albumin fusion proteins |
| 10/25/2001 | CA2405525A1 Albumin fusion proteins |
| 10/25/2001 | CA2405377A1 Nutritional modules |
| 10/25/2001 | CA2404129A1 Codon optimisation for expression in retrovirus packaging cells |
| 10/24/2001 | EP1148063A1 Composition containing hemostatic activ vWF and process for its preparation |
| 10/24/2001 | EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms |
| 10/24/2001 | EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 10/24/2001 | EP1147774A1 Method for improving the quality of sperm for artificial insemination of animals |
| 10/24/2001 | EP1147227A1 Lipophilic quenching of viral inactivating agents |
| 10/24/2001 | EP1147190A1 Her-2/neu fusion proteins |
| 10/24/2001 | EP1147186A1 In vitro activated gamma delta lymphocytes |
| 10/24/2001 | EP1147181A2 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 10/24/2001 | EP1147179A2 Human liver progenitors |
| 10/24/2001 | EP1147176A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 10/24/2001 | EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
| 10/24/2001 | EP1147125A1 Brain-derived alkali-soluble immunoregulatory composition |
| 10/24/2001 | EP1146907A2 Use of cationic lipids to generate anti-tumor immunity |
| 10/24/2001 | EP1146898A1 Vaccine-mediated treatment of neurological disorders |
| 10/24/2001 | EP1146897A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 10/24/2001 | EP1146895A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 10/24/2001 | EP1146885A1 Pre-conditioning against cell death |
| 10/24/2001 | EP0731709B1 Neutrophil inhibitors from nematodes |
| 10/24/2001 | EP0633027B1 Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same |
| 10/24/2001 | CN2455638Y Protective lid for liquified nitrogen biological container |
| 10/24/2001 | CN1319140A Recombinant CELO virus and CELO virus DNA |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1319019A i(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists |
| 10/24/2001 | CN1318412A Recipe and preparation process of hemopoietic capsule |
| 10/24/2001 | CN1318408A External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation |
| 10/24/2001 | CN1318407A Chinese medicine for treating prostata proliferation and hypertrophy |
| 10/24/2001 | CN1318400A Medicine for treating spermacrasia and its preparation process |
| 10/24/2001 | CN1318394A 延年益寿保健药品 Longevity health drugs |
| 10/24/2001 | CN1318392A Beriberi treating ointment |
| 10/24/2001 | CN1318388A Eye disease preventing oral liquid and its preparation |
| 10/24/2001 | CN1318387A Wound-treating external-use medicine |
| 10/24/2001 | CN1318385A Specific compound impotence treating preparation and its preparation |
| 10/24/2001 | CN1318375A Preparation of coronary heart disease treating medicine powder |
| 10/24/2001 | CN1318374A Preparation of Xinnaomaitong injecta for promoting blood circulation |
| 10/24/2001 | CN1073443C Medicine for treatment of myopia |
| 10/24/2001 | CN1073439C Medicine for treating tracheitis and asthma and its preparation |
| 10/24/2001 | CN1073437C Chinese medicine for treating digestive tract inflammation and ulcer and its prep. |
| 10/24/2001 | CN1073433C Medicine for psoriasis and preparing method thereof |
| 10/24/2001 | CN1073431C Medicine for conditioning intestine and treating diarrhea |
| 10/24/2001 | CN1073429C Scorpion health-care wine |
| 10/24/2001 | CN1073425C Clystering liquid for curing lupus colonitis |
| 10/24/2001 | CN1073380C Hypolycemic health-care egg and its preparing process |
| 10/23/2001 | US6306922 Macromer polymers crosslinked by photopolymerization |
| 10/23/2001 | US6306652 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/23/2001 | US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease |
| 10/23/2001 | US6306622 cDNA encoding a BMP type II receptor |
| 10/23/2001 | US6306391 Coating agent and/or microorganism to provide a protective barrier; combining agent and microorganism into form of capsules or tablets; barrier protects microogranism from effect of anti-infective agent |
| 10/23/2001 | US6306388 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 10/23/2001 | CA2196096C Slimming composition containing a neuropeptide y receptor antagonist |
| 10/23/2001 | CA1341308C Vaccines against avian herpes viruses |
| 10/23/2001 | CA1341307C Nucleotide sequences of avian herpes viruses |
| 10/19/2001 | CA2304123A1 Antibacterial therapy for multi-drug resistant bacteria |
| 10/18/2001 | WO2001077358A2 Herpes viruses for immune modulation |
| 10/18/2001 | WO2001077339A1 Human pyruvate dehydrogenese phosphatase |
| 10/18/2001 | WO2001077303A2 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 10/18/2001 | WO2001077300A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 10/18/2001 | WO2001077299A2 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
| 10/18/2001 | WO2001077298A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 10/18/2001 | WO2001077157A2 FULL-LENGTH gb virus c (HEPATITIS G VIRUS) RNA TRANSCRIPTS ARE INFECTIOUS IN PRIMARY CD4 POSITIVE T CELLS AND METHODS OF TREATING HIV |
| 10/18/2001 | WO2001077137A1 Albumin fusion proteins |
| 10/18/2001 | WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 10/18/2001 | WO2001077115A1 Antitumoral ecteinascidin derivatives |
| 10/18/2001 | WO2001076654A1 Methods and compositions for treating intervertebral disc degeneration |
| 10/18/2001 | WO2001076613A1 Extract for abstaining from narcotics and its preparation |
| 10/18/2001 | WO2001076612A1 METHOD FOR PRODUCING NEMATOCIDAL COMPOSITION BY HEAT TREATING A pH-ADJUSTED FERMENTATION BROTH |
| 10/18/2001 | WO2001076611A1 Method for preparing a cellular graft from fetal tissues |
| 10/18/2001 | WO2001076531A2 Bile acid containing prodrugs with enhanced bioavailability |
| 10/18/2001 | WO2001076507A2 Use of oxygen carriers to improve grafted cell survival in neural transplantation |
| 10/18/2001 | WO2001076381A1 Protein stabilised emulsions |
| 10/18/2001 | WO2001076360A2 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
| 10/18/2001 | WO2001045737A3 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 10/18/2001 | WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 10/18/2001 | WO2001031015A3 36p6d5: secreted tumor antigen |
| 10/18/2001 | WO2001026604A3 Hair and scalp treatment method and recipes for application of this method |
| 10/18/2001 | WO2001021201A3 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 10/18/2001 | WO2001015715A3 Composition for maintenance of bone or dental health or treatment of bone or dental disorders |
| 10/18/2001 | WO2000057837A9 Compositions and methods for effecting the levels of cholesterol |
| 10/18/2001 | WO2000044893A9 In vitro activated gamma delta lymphocytes |
| 10/18/2001 | WO2000043498A9 Human liver progenitors |
| 10/18/2001 | WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage |
| 10/18/2001 | WO2000037635A3 Genetic suppressor elements against human immunodeficiency virus |
| 10/18/2001 | WO2000032233A3 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 10/18/2001 | WO2000020041A9 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |